ProQR Therapeutics NV
F:0PQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ProQR Therapeutics NV
F:0PQ
|
NL |
|
Atlas Copco AB
STO:ATCO A
|
SE |
|
M
|
Mesoblast Ltd
F:LWB
|
AU |
|
V
|
Vestas Wind Systems A/S
XMUN:VWSB
|
DK |
|
C
|
CMOC Group Ltd
XMUN:D7N
|
CN |
|
K
|
KDDI Corp
XMUN:DIP
|
JP |
|
S
|
Seven & i Holdings Co Ltd
SWB:S6M
|
JP |
|
Telkom Indonesia (Persero) Tbk PT
NYSE:TLK
|
ID |
|
K
|
Keurig Dr Pepper Inc
XMUN:DP5
|
US |
|
L
|
Laboratory Corporation of America Holdings
SWB:LAB
|
US |
|
Paramount Global
NASDAQ:PARA
|
US |
|
A
|
AXA SA
XHAM:AXA
|
FR |
|
I
|
Invesco Ltd
LSE:0UAN
|
US |
|
M
|
Micron Technology Inc
SWB:MTE
|
US |
|
Belimo Holding AG
SIX:BEAN
|
CH |
|
Dominion Energy Inc
NYSE:D
|
US |
|
M
|
Magna International Inc
SWB:MGA
|
CA |
|
Nicox SA
F:NXOA
|
FR |
|
Brookfield Corp
TSX:BN
|
CA |
|
R
|
RH
DUS:RS1
|
US |
|
W
|
Wheaton Precious Metals Corp
SWB:SII
|
CA |
Wall St Price Targets
0PQ Price Targets Summary
ProQR Therapeutics NV
According to Wall Street analysts, the average 1-year price target for
0PQ is 8.247 EUR with a low forecast of 3.63 EUR and a high forecast of 13.207 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0PQ's stock price target?
Price Target
8.247
EUR
According to Wall Street analysts, the average 1-year price target for
0PQ is 8.247 EUR with a low forecast of 3.63 EUR and a high forecast of 13.207 EUR.
What is the Revenue forecast for ProQR Therapeutics NV?
Projected CAGR
65%
Over the last 12 years, the compound annual growth rate for Revenue has been 51%. The projected CAGR for the next 3 years is 65%.